nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—Basal cell carcinoma—Bupropion—obesity	0.0366	0.0615	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PRKCD—obesity	0.0173	0.0426	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—CTSS—obesity	0.0147	0.0365	CbGpPWpGaD
Methyl aminolevulinate—Blister—Sibutramine—obesity	0.0137	0.0231	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Sibutramine—obesity	0.0127	0.0213	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—NCF2—obesity	0.0124	0.0307	CbGpPWpGaD
Methyl aminolevulinate—Rash pustular—Sibutramine—obesity	0.0124	0.0208	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3R1—obesity	0.0118	0.0291	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—TRIM32—obesity	0.0117	0.0289	CbGpPWpGaD
Methyl aminolevulinate—Eyelid oedema—Topiramate—obesity	0.0109	0.0183	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3CB—obesity	0.0109	0.0268	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—PTPN1—obesity	0.0106	0.0262	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis contact—Sibutramine—obesity	0.00978	0.0164	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—SOCS1—obesity	0.00944	0.0233	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—SOCS3—obesity	0.00932	0.0231	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Methamphetamine—obesity	0.00883	0.0148	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—SH2B1—obesity	0.00868	0.0214	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—GH1—obesity	0.00868	0.0214	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Benzphetamine—obesity	0.00851	0.0143	CcSEcCtD
Methyl aminolevulinate—Erythema—Diethylpropion—obesity	0.00851	0.0143	CcSEcCtD
Methyl aminolevulinate—Eczema—Orlistat—obesity	0.00826	0.0139	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Methamphetamine—obesity	0.00819	0.0137	CcSEcCtD
Methyl aminolevulinate—Eczema—Sibutramine—obesity	0.00799	0.0134	CcSEcCtD
Methyl aminolevulinate—Oedema—Phentermine—obesity	0.00798	0.0134	CcSEcCtD
Methyl aminolevulinate—Eye pain—Sibutramine—obesity	0.00796	0.0134	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Topiramate—obesity	0.00791	0.0133	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Benzphetamine—obesity	0.0079	0.0133	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Orlistat—obesity	0.00777	0.013	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—PRKCD—obesity	0.00766	0.0189	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis bullous—Sibutramine—obesity	0.00752	0.0126	CcSEcCtD
Methyl aminolevulinate—Dizziness—Methamphetamine—obesity	0.00735	0.0123	CcSEcCtD
Methyl aminolevulinate—Discomfort—Diethylpropion—obesity	0.00716	0.012	CcSEcCtD
Methyl aminolevulinate—Dizziness—Benzphetamine—obesity	0.00709	0.0119	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—CD36—obesity	0.00702	0.0173	CbGpPWpGaD
Methyl aminolevulinate—Eczema—Bupropion—obesity	0.00697	0.0117	CcSEcCtD
Methyl aminolevulinate—Headache—Methamphetamine—obesity	0.00696	0.0117	CcSEcCtD
Methyl aminolevulinate—Eye pain—Bupropion—obesity	0.00694	0.0117	CcSEcCtD
Methyl aminolevulinate—Face oedema—Sibutramine—obesity	0.00694	0.0116	CcSEcCtD
Methyl aminolevulinate—Fatigue—Phentermine—obesity	0.00688	0.0116	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PRKCD—obesity	0.00674	0.0167	CbGpPWpGaD
Methyl aminolevulinate—Headache—Benzphetamine—obesity	0.00671	0.0113	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3CA—obesity	0.00662	0.0164	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—ICAM1—obesity	0.00654	0.0162	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Phendimetrazine—obesity	0.00646	0.0108	CcSEcCtD
Methyl aminolevulinate—Nausea—Benzphetamine—obesity	0.00637	0.0107	CcSEcCtD
Methyl aminolevulinate—Urticaria—Phentermine—obesity	0.00634	0.0107	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Phenylpropanolamine—obesity	0.00615	0.0103	CcSEcCtD
Methyl aminolevulinate—Headache—Phendimetrazine—obesity	0.00612	0.0103	CcSEcCtD
Methyl aminolevulinate—Face oedema—Bupropion—obesity	0.00605	0.0102	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TRIM32—obesity	0.00604	0.0149	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CTSS—obesity	0.00589	0.0146	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Phendimetrazine—obesity	0.0058	0.00974	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—TRIM32—obesity	0.0058	0.0143	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Phentermine—obesity	0.00573	0.00962	CcSEcCtD
Methyl aminolevulinate—Fatigue—Cimetidine—obesity	0.0057	0.00957	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Sibutramine—obesity	0.00567	0.00952	CcSEcCtD
Methyl aminolevulinate—Urticaria—Diethylpropion—obesity	0.00552	0.00927	CcSEcCtD
Methyl aminolevulinate—Dizziness—Phenylpropanolamine—obesity	0.00552	0.00927	CcSEcCtD
Methyl aminolevulinate—Dizziness—Phentermine—obesity	0.00528	0.00887	CcSEcCtD
Methyl aminolevulinate—Rash—Phenylpropanolamine—obesity	0.00526	0.00883	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Phenylpropanolamine—obesity	0.00526	0.00883	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—PTPN1—obesity	0.00517	0.0128	CbGpPWpGaD
Methyl aminolevulinate—Rash—Phentermine—obesity	0.00503	0.00845	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Phentermine—obesity	0.00503	0.00845	CcSEcCtD
Methyl aminolevulinate—Headache—Phentermine—obesity	0.005	0.0084	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IFNG—obesity	0.00498	0.0123	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—NCF2—obesity	0.00496	0.0123	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Phenylpropanolamine—obesity	0.00496	0.00832	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Bupropion—obesity	0.00494	0.0083	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Cimetidine—obesity	0.00487	0.00818	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CFD—obesity	0.00486	0.012	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Phentermine—obesity	0.00474	0.00796	CcSEcCtD
Methyl aminolevulinate—Asthenia—Cimetidine—obesity	0.00474	0.00796	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Sibutramine—obesity	0.00464	0.0078	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—SOCS1—obesity	0.00461	0.0114	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Diethylpropion—obesity	0.00459	0.00771	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3R1—obesity	0.00459	0.0113	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—SOCS3—obesity	0.00455	0.0113	CbGpPWpGaD
Methyl aminolevulinate—Eczema—Topiramate—obesity	0.00444	0.00746	CcSEcCtD
Methyl aminolevulinate—Eye pain—Topiramate—obesity	0.00442	0.00742	CcSEcCtD
Methyl aminolevulinate—Rash—Diethylpropion—obesity	0.00438	0.00735	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Diethylpropion—obesity	0.00438	0.00735	CcSEcCtD
Methyl aminolevulinate—Dizziness—Cimetidine—obesity	0.00437	0.00734	CcSEcCtD
Methyl aminolevulinate—Headache—Diethylpropion—obesity	0.00435	0.00731	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—DEFB1—obesity	0.00434	0.0107	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CB—obesity	0.00424	0.0105	CbGpPWpGaD
Methyl aminolevulinate—Rash—Cimetidine—obesity	0.00417	0.007	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Cimetidine—obesity	0.00416	0.00699	CcSEcCtD
Methyl aminolevulinate—Headache—Cimetidine—obesity	0.00414	0.00695	CcSEcCtD
Methyl aminolevulinate—Nausea—Diethylpropion—obesity	0.00413	0.00693	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Bupropion—obesity	0.00405	0.0068	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—CASP1—obesity	0.00398	0.00985	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Cimetidine—obesity	0.00393	0.00659	CcSEcCtD
Methyl aminolevulinate—Face oedema—Topiramate—obesity	0.00385	0.00647	CcSEcCtD
Methyl aminolevulinate—Discomfort—Orlistat—obesity	0.00376	0.00632	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—PRKCD—obesity	0.00374	0.00924	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTSC—obesity	0.00373	0.00923	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—LBP—obesity	0.00369	0.00911	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Orlistat—obesity	0.00365	0.00613	CcSEcCtD
Methyl aminolevulinate—Discomfort—Sibutramine—obesity	0.00364	0.00611	CcSEcCtD
Methyl aminolevulinate—Infection—Orlistat—obesity	0.00362	0.00609	CcSEcCtD
Methyl aminolevulinate—Oedema—Sibutramine—obesity	0.00353	0.00593	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—TRIM32—obesity	0.00352	0.00869	CbGpPWpGaD
Methyl aminolevulinate—Infection—Sibutramine—obesity	0.00351	0.00589	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PTPN1—obesity	0.00345	0.00854	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—SOCS1—obesity	0.00335	0.00828	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—SOCS3—obesity	0.00331	0.00818	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PRL—obesity	0.00329	0.00815	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Orlistat—obesity	0.00328	0.0055	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—ICAM1—obesity	0.0032	0.0079	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Bupropion—obesity	0.00317	0.00533	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Sibutramine—obesity	0.00317	0.00532	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Topiramate—obesity	0.00315	0.00529	CcSEcCtD
Methyl aminolevulinate—Fatigue—Orlistat—obesity	0.00315	0.00528	CcSEcCtD
Methyl aminolevulinate—Pain—Orlistat—obesity	0.00312	0.00524	CcSEcCtD
Methyl aminolevulinate—Oedema—Bupropion—obesity	0.00308	0.00517	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—SOCS1—obesity	0.00308	0.00761	CbGpPWpGaD
Methyl aminolevulinate—Infection—Bupropion—obesity	0.00306	0.00514	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—SOCS3—obesity	0.00304	0.00752	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CTSS—obesity	0.00304	0.00751	CbGpPWpGaD
Methyl aminolevulinate—Pain—Sibutramine—obesity	0.00302	0.00507	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTSS—obesity	0.00292	0.00721	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Orlistat—obesity	0.0029	0.00487	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CFD—obesity	0.00283	0.007	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—GH1—obesity	0.00283	0.007	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SH2B1—obesity	0.00283	0.007	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Sibutramine—obesity	0.00281	0.00471	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CD36—obesity	0.0028	0.00693	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL18—obesity	0.00277	0.00685	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Bupropion—obesity	0.00276	0.00464	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PRKG1—obesity	0.00275	0.00681	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Orlistat—obesity	0.00269	0.00451	CcSEcCtD
Methyl aminolevulinate—Fatigue—Bupropion—obesity	0.00265	0.00446	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PRKAR2B—obesity	0.00265	0.00654	CbGpPWpGaD
Methyl aminolevulinate—Pain—Bupropion—obesity	0.00263	0.00442	CcSEcCtD
Methyl aminolevulinate—Asthenia—Orlistat—obesity	0.00262	0.0044	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Sibutramine—obesity	0.0026	0.00437	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—TYK2—obesity	0.0026	0.00642	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—obesity	0.00258	0.00639	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Orlistat—obesity	0.00258	0.00433	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Topiramate—obesity	0.00258	0.00433	CcSEcCtD
Methyl aminolevulinate—Asthenia—Sibutramine—obesity	0.00253	0.00425	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—DEFB1—obesity	0.00253	0.00624	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Sibutramine—obesity	0.0025	0.0042	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PRKCD—obesity	0.0025	0.00617	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NCF2—obesity	0.00245	0.00607	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Bupropion—obesity	0.00245	0.00411	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNG—obesity	0.00243	0.00601	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Orlistat—obesity	0.00241	0.00405	CcSEcCtD
Methyl aminolevulinate—Erythema—Topiramate—obesity	0.0024	0.00404	CcSEcCtD
Methyl aminolevulinate—Dizziness—Sibutramine—obesity	0.00234	0.00392	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IRS2—obesity	0.00232	0.00574	CbGpPWpGaD
Methyl aminolevulinate—Rash—Orlistat—obesity	0.0023	0.00386	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Orlistat—obesity	0.0023	0.00386	CcSEcCtD
Methyl aminolevulinate—Headache—Orlistat—obesity	0.00229	0.00384	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Bupropion—obesity	0.00227	0.00381	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CTSC—obesity	0.00227	0.0056	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CASP1—obesity	0.00223	0.00552	CbGpPWpGaD
Methyl aminolevulinate—Rash—Sibutramine—obesity	0.00223	0.00374	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Sibutramine—obesity	0.00222	0.00374	CcSEcCtD
Methyl aminolevulinate—Headache—Sibutramine—obesity	0.00221	0.00371	CcSEcCtD
Methyl aminolevulinate—Asthenia—Bupropion—obesity	0.00221	0.00371	CcSEcCtD
Methyl aminolevulinate—Pruritus—Bupropion—obesity	0.00218	0.00366	CcSEcCtD
Methyl aminolevulinate—Nausea—Orlistat—obesity	0.00217	0.00364	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—LBP—obesity	0.00215	0.00531	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—ICAM1—obesity	0.00213	0.00527	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Sibutramine—obesity	0.0021	0.00352	CcSEcCtD
Methyl aminolevulinate—Dizziness—Bupropion—obesity	0.00204	0.00342	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IRS1—obesity	0.00203	0.00501	CbGpPWpGaD
Methyl aminolevulinate—Discomfort—Topiramate—obesity	0.00202	0.00339	CcSEcCtD
Methyl aminolevulinate—Oedema—Topiramate—obesity	0.00196	0.00329	CcSEcCtD
Methyl aminolevulinate—Infection—Topiramate—obesity	0.00195	0.00327	CcSEcCtD
Methyl aminolevulinate—Rash—Bupropion—obesity	0.00194	0.00326	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD40—obesity	0.00194	0.0048	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis—Bupropion—obesity	0.00194	0.00326	CcSEcCtD
Methyl aminolevulinate—Headache—Bupropion—obesity	0.00193	0.00324	CcSEcCtD
Methyl aminolevulinate—Nausea—Bupropion—obesity	0.00183	0.00307	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CD—obesity	0.0018	0.00446	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTSS—obesity	0.00177	0.00437	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Topiramate—obesity	0.00176	0.00296	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FOXO3—obesity	0.00176	0.00434	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—TYK2—obesity	0.00173	0.00429	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—SOCS1—obesity	0.00173	0.00427	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3R1—obesity	0.0017	0.00421	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Topiramate—obesity	0.00169	0.00284	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FOXO3—obesity	0.00169	0.00417	CbGpPWpGaD
Methyl aminolevulinate—Pain—Topiramate—obesity	0.00168	0.00282	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PRKG1—obesity	0.00167	0.00413	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—SOCS1—obesity	0.00166	0.0041	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—SOCS3—obesity	0.00164	0.00405	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNG—obesity	0.00162	0.00401	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CB—obesity	0.00157	0.00388	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Topiramate—obesity	0.00156	0.00262	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PRKAR2B—obesity	0.00154	0.00381	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FOXO1—obesity	0.00151	0.00373	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NCF2—obesity	0.00149	0.00368	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FOXO1—obesity	0.00145	0.00358	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1B—obesity	0.00145	0.00358	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Topiramate—obesity	0.00144	0.00243	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD36—obesity	0.00144	0.00357	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Topiramate—obesity	0.00141	0.00236	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PRKCD—obesity	0.0014	0.00346	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Topiramate—obesity	0.00139	0.00233	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD36—obesity	0.00139	0.00343	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—C3—obesity	0.00137	0.00338	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—C3—obesity	0.00131	0.00325	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IRS2—obesity	0.0013	0.00322	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CRP—obesity	0.0013	0.00322	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CASP1—obesity	0.0013	0.00322	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Topiramate—obesity	0.0013	0.00218	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—IRS2—obesity	0.00125	0.00309	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TLR4—obesity	0.00125	0.00309	CbGpPWpGaD
Methyl aminolevulinate—Rash—Topiramate—obesity	0.00124	0.00208	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Topiramate—obesity	0.00124	0.00207	CcSEcCtD
Methyl aminolevulinate—Headache—Topiramate—obesity	0.00123	0.00206	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—STAT3—obesity	0.00121	0.003	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BAD—obesity	0.00119	0.00293	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD40—obesity	0.00118	0.00291	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Topiramate—obesity	0.00116	0.00196	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PRKCB—obesity	0.00115	0.00285	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ICAM1—obesity	0.00115	0.00284	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—BAD—obesity	0.00114	0.00282	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IRS1—obesity	0.00114	0.00281	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTPN1—obesity	0.00113	0.00279	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—IRS1—obesity	0.00109	0.0027	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PRL—obesity	0.00108	0.00266	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AKT2—obesity	0.00105	0.0026	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FOXO3—obesity	0.00102	0.00253	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CD—obesity	0.00101	0.0025	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—AKT2—obesity	0.00101	0.0025	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SOCS1—obesity	0.00101	0.00249	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SOCS3—obesity	0.000993	0.00246	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TYK2—obesity	0.000972	0.0024	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CD—obesity	0.000971	0.0024	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CA—obesity	0.000958	0.00237	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3R1—obesity	0.000954	0.00236	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BCL2—obesity	0.000919	0.00227	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3R1—obesity	0.000916	0.00227	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL18—obesity	0.000905	0.00224	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MTOR—obesity	0.000881	0.00218	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CB—obesity	0.000881	0.00218	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FOXO1—obesity	0.000879	0.00217	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6—obesity	0.000848	0.0021	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—MTOR—obesity	0.000846	0.00209	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CB—obesity	0.000846	0.00209	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD36—obesity	0.000841	0.00208	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PRKCD—obesity	0.000816	0.00202	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—C3—obesity	0.000797	0.00197	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IRS2—obesity	0.000758	0.00187	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CRP—obesity	0.000758	0.00187	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK8—obesity	0.000745	0.00184	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TLR4—obesity	0.000727	0.0018	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PRKCB—obesity	0.0007	0.00173	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ICAM1—obesity	0.000697	0.00172	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BAD—obesity	0.000691	0.00171	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IRS1—obesity	0.000662	0.00164	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AKT2—obesity	0.000613	0.00151	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CD—obesity	0.000589	0.00146	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TYK2—obesity	0.000566	0.0014	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3R1—obesity	0.000556	0.00137	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CA—obesity	0.000537	0.00133	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL2—obesity	0.000535	0.00132	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IFNG—obesity	0.00053	0.00131	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CA—obesity	0.000516	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CB—obesity	0.000513	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MTOR—obesity	0.000513	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6—obesity	0.000476	0.00118	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1B—obesity	0.000473	0.00117	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AKT1—obesity	0.000439	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK8—obesity	0.000434	0.00107	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—AKT1—obesity	0.000421	0.00104	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STAT3—obesity	0.000397	0.00098	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CA—obesity	0.000313	0.000773	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6—obesity	0.000277	0.000685	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AKT1—obesity	0.000256	0.000632	CbGpPWpGaD
